Pharmacology & ToxicologybioRxivPreprint
Development of a novel, pan-variant aerosol intervention for COVID-19
R. H. Shoemaker, R. A. Panettieri, S. K. Libutti…·G. Wirnsberger
This paper reports preclinical development and evaluation of aerosolized soluble recombinant human ACE2 (APN01) as a COVID-19 intervention.
DOI 10.1101/2021.09.14.459961